Doximity (NYSE:DOCS) Price Target Raised to $31.00

Дата публикации: 10-08-2026 05:36:49

Doximity (NYSE:DOCS – Free Report) had its target price increased by JPMorgan Chase & Co. from $26.00 to $31.00 in a report issued on Friday morning,Benzinga reports. They currently have a neutral rating on the stock. Other equities analysts have also recently issued reports about the company. Morgan Stanley dropped their price objective on Doximity […]

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Doximity’s (DOCS) “Overweight” Rating Reiterated at Piper Sandler	0	9.98	10-08-2026
2	Odyssey Therapeutics (NASDAQ:ODTX) Price Target Raised to $29.00	0	14.24	10-08-2026
3	Target (NYSE:TGT) Price Target Raised to $157.00	0	13.85	10-08-2026
4	DraftKings (NASDAQ:DKNG) Price Target Raised to $30.00	0	11.9	10-08-2026
5	Genpact (NYSE:G) Price Target Raised to $45.00	0	14.26	10-08-2026
6	MKS (NASDAQ:MKSI) Price Target Raised to $380.00	0	13.85	10-08-2026
7	Replimune Group (NASDAQ:REPL) Price Target Raised to $20.00	0	13.83	10-08-2026
8	TG Therapeutics (NASDAQ:TGTX) Price Target Raised to $72.00	0	13.04	10-08-2026
9	Sotera Health (NASDAQ:SHC) Price Target Raised to $18.00	0	12.25	10-08-2026
10	Royalty Pharma (NASDAQ:RPRX) Price Target Raised to $62.00	0	13.82	10-08-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 12.67. Источник: www.americanbankingnews.com.